Post Marketing Surveillance Study of Byetta (Exenatide) Use Among Filipino Patients
Phase of Trial: Phase IV
Latest Information Update: 04 Nov 2016
At a glance
- Drugs Exenatide (Primary) ; Metformin; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Amylin Pharmaceuticals
- 10 Jun 2017 Biomarkers information updated
- 13 Dec 2010 Planned end date changed from 1 May 2010 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 05 Mar 2008 New trial record.